SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Astec LifeSciences submits newspaper advertisement

17 Aug 2022 Evaluate

In continuation to intimations dated 25th July, 2022 and 16th August, 2022 and pursuant to Regulations 30 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Astec LifeSciences has informed that it enclosed copies of the newspaper advertisement published on Wednesday, 17th August, 2022, informing about the dispatch of the Postal Ballot Notice to the Members of the company. The Notice has been published in the newspapers: Business Standard- All Editions (in English language) and Mumbai Lakshadeep - Mumbai Edition (in Marathi language). The intimation is also uploaded on Company’s website: www.astecls.com.

The above information is a part of company’s filings submitted to BSE.

Astec Lifesciences Share Price

726.50 -22.90 (-3.06%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
UPL 665.00
PI Industries 3144.45
Bayer CropScience 4900.45
Sharda Cropchem 1109.70
Sumitomo Chemical 441.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×